Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian Cohort

Documenti analoghi

• A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real‐world practice
  di: Monica Messina, et al.
  Pubblicazione: (2024)
• Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched‐cohort analysis
  di: Michael R. Grunwald, et al.
  Pubblicazione: (2024)
• Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients
  di: Alfonso Piciocchi, et al.
  Pubblicazione: (2024)
• Leukemic Regression After G‐CSF Withdrawal in Severe Congenital Neutropenia
  di: Agnese Roveta, et al.
  Pubblicazione: (2026)
• Next Generation Sequencing Allows Identification of a Novel Mutation in the TfR2 Gene and Outperforms the Conventional Diagnostic Techniques
  di: Miriam Longo, et al.
  Pubblicazione: (2025)